Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It.

about

Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.

P2860

Q50065359-FEED746F-60E1-4302-83B8-160F08FC063F

P2860

Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It.

Item

http://www.wikidata.org/entity/Q40346731

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prevention of Staphylococcus a ...... onal Antibiotics Won't Cut It.

@en

type

Item

label

Prevention of Staphylococcus a ...... onal Antibiotics Won't Cut It.

@en

prefLabel

Prevention of Staphylococcus a ...... onal Antibiotics Won't Cut It.

@en

P1476

Prevention of Staphylococcus a ...... onal Antibiotics Won't Cut It.

@en

P2860

Methicillin-resistant Staphylococcus aureus therapy: past, present, and future

The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review

Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis

Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.

A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia

P304

1089-1091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/CID/CIX060

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason Burnham

Marin H Kollef

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28158521

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic

ventilator

P932

5850453

http://www.w3.org/2001/XMLSchema#string

Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It.

about

P2860

P2860

Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932